Accession | ARO:3004492 |
Synonym(s) | Sirturo |
Definition | A diarylquinoline antibiotic drug sold under the brand name Sirturo, used to treat infection from Mycobacterium spp., particularly multidrug-resistant tuberculosis. Bedaquiline disrupts ATP synthase by proton pump blockage, inhibiting ATP synthesis. |
SMILES | COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12 |
PubChem | 5388906 |
ChEMBL | CHEMBL376488 |
ChEBI | 72292 |
CAS | 843663-66-1 |
Drug Class | diarylquinoline antibiotic |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + diarylquinoline antibiotic [Drug Class] |
Sub-Term(s) | 4 ontology terms | Show + Mycobacterium abscessus atpE with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis Rv0678 with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis Rv2535c with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis atpE with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic |
Publications | Deoghare S, et al. . Indian J Pharmacol 45(5):536-7 Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis. (PMID 24130398) |
Curator | Description | Most Recent Edit |
---|